Australian Women File Class Action Suit Against J&J over Pelvic Mesh Implants
The claim, which is being heard in Australia’s Federal Court, said patients had suffered chronic pain, bleeding and severe discomfort during sexual intercourse since having the mesh surgically implanted. The devices are used to treat stress urinary incontinence and pelvic organ prolapse.
The Australian action was brought on behalf of more than 700 claimants.
Johnson & Johnson said it was only aware of 200 “product events” after selling more than 100,000 pelvic floor repair products in Australia.
“It is always a concern to us when a patient doesn’t get the outcome they had hoped for, or believes they have experienced an adverse event,” spokeswoman Meshlin Khouri said in a statement.
“However it is important to remember that the majority of women who have undergone this surgery have had a positive result, and it has improved their quality of life.”
Johnson & Johnson is one of several manufacturers that sold the devices. Those companies are facing tens of thousands of individual lawsuits from plaintiffs who said they were injured by the mesh’s poor design and substandard materials.
In May, California accused Johnson & Johnson of failing to warn doctors and patients about the severity and frequency of complications associated with its pelvic mesh devices.
An Australian parliamentary committee is also holding an inquiry into the products and is expected to report its findings at the end of November.
(Reporting by Ben Cooper; editing by Jonathan Barrett and Edwina Gibbs)
Related:
- Jury Orders J&J to Pay $20 Million in Vaginal Mesh Case
- Jury Awards $3.35M in Vaginal Mesh Case Against J&J
- Public Adjuster Accused of Swiping $600,000 in Hurricane Ian Insurance Payments
- Viewpoint: California’s Surplus Lines HO Market Driven by Access, Not Wildfire Risk
- Agency Customer Rep and Miami Businessman Killed in Separate Boat Accidents
- Farmers Insurance Plans Historic, Rapid Expansion of Agency Force